Literature DB >> 17451570

Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease.

K Kaukinen1, M Peräaho, K Lindfors, J Partanen, N Woolley, P Pikkarainen, A-L Karvonen, T Laasanen, H Sievänen, M Mäki, P Collin.   

Abstract

BACKGROUND: Refractory sprue with malabsorption carries a risk of lymphoma. AIM: To examine whether a good clinical but poor histological response during a strict gluten-free diet predicts a poor outcome.
METHODS: The study involved all coeliac patients who showed no histological recovery within 2 years on a strict gluten-free diet. Small intestinal biopsy and bone mineral density were investigated in 2001 and clinical features were followed up until 2005. The results were compared to those in 18 coeliac patients with a good histological recovery.
RESULTS: Thirteen coeliac patients had persistent small intestinal villous atrophy despite maintaining gluten-free diet. All had demonstrated a good clinical response. Osteoporosis was found in 58% and 22% of the non-responders and responders, respectively (P = 0.04). In 2005, two of the non-responders had developed symptomatic refractory sprue, one died of lymphoma and one of carcinoid tumour, and one gastric adenocarcinoma was operated. None of the 18 controls had developed refractory sprue or malignancy. The frequency of histological non-responsive disease was 1.9%.
CONCLUSIONS: Persistent villous atrophy in adult coeliac disease, even in the absence of symptoms, carries a risk of subsequent severe complications. The follow-up biopsy is important in detecting these individuals.

Entities:  

Mesh:

Year:  2007        PMID: 17451570     DOI: 10.1111/j.1365-2036.2007.03311.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  47 in total

Review 1.  Classification and management of refractory coeliac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

2.  Impact of mass screening for gluten-sensitive enteropathy in working population.

Authors:  Meritxell Mariné; Fernando Fernández-Bañares; Montserrat Alsina; Carme Farré; Montserrat Cortijo; Rebeca Santaolalla; Antonio Salas; Margarita Tomàs; Elias Abugattas; Carme Loras; Ingrid Ordás; Josep-M Viver; Maria Esteve
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

3.  Recent advances in celiac disease.

Authors:  Hugh James Freeman; Angeli Chopra; Michael Tom Clandinin; Alan Br Thomson
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

4.  Predictors and Significance of Incomplete Mucosal Recovery in Celiac Disease After 1 Year on a Gluten-Free Diet.

Authors:  Henna Pekki; Kalle Kurppa; Markku Mäki; Heini Huhtala; Harri Sievänen; Kaija Laurila; Pekka Collin; Katri Kaukinen
Journal:  Am J Gastroenterol       Date:  2015-06-02       Impact factor: 10.864

Review 5.  Practical insights into gluten-free diets.

Authors:  Jacalyn A See; Katri Kaukinen; Govind K Makharia; Peter R Gibson; Joseph A Murray
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-22       Impact factor: 46.802

Review 6.  The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis.

Authors:  Carolina Ciacci; Paul Ciclitira; Marios Hadjivassiliou; Katri Kaukinen; Jonas F Ludvigsson; Norma McGough; David S Sanders; Jeremy Woodward; Jonathan N Leonard; Gillian L Swift
Journal:  United European Gastroenterol J       Date:  2015-04       Impact factor: 4.623

7.  Persistent mucosal damage and risk of fracture in celiac disease.

Authors:  Benjamin Lebwohl; Karl Michaëlsson; Peter H R Green; Jonas F Ludvigsson
Journal:  J Clin Endocrinol Metab       Date:  2014-01-16       Impact factor: 5.958

8.  Is it gluten-free? Relationship between self-reported gluten-free diet adherence and knowledge of gluten content of foods.

Authors:  Jocelyn A Silvester; Dayna Weiten; Lesley A Graff; John R Walker; Donald R Duerksen
Journal:  Nutrition       Date:  2016-02-13       Impact factor: 4.008

9.  Predictors of persistent villous atrophy in coeliac disease: a population-based study.

Authors:  B Lebwohl; J A Murray; A Rubio-Tapia; P H R Green; J F Ludvigsson
Journal:  Aliment Pharmacol Ther       Date:  2014-01-16       Impact factor: 8.171

10.  ACG clinical guidelines: diagnosis and management of celiac disease.

Authors:  Alberto Rubio-Tapia; Ivor D Hill; Ciarán P Kelly; Audrey H Calderwood; Joseph A Murray
Journal:  Am J Gastroenterol       Date:  2013-04-23       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.